Advisory Services Network, LLC Glycomimetics Inc Transaction History

Advisory Services Network, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.44 - $2.14 $45,792 - $68,052	-31,800 Closed	0 $0
Q3 2021 Nov 05, 2021	SELL	$1.8 - $2.39 $7,200 - $9,560	-4,000 Reduced 11.17%	31,800 $70,000
Q2 2021 Aug 12, 2021	BUY	$2.16 - $3.18 $77,328 - $113,844	35,800 New	35,800 $83,000

17.8M

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $16.8M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.